Related Experiment Videos
Prospective studies of homocysteine and cardiovascular disease
1Department of Epidemiology and Public Health, Agricultural University, Wageningen, The Netherlands.
Insights
Elevated homocysteine levels are strongly linked to vascular disease risk. While early studies suggest this connection, prospective research is crucial to confirm causality and understand cardiovascular disease manifestations.
Area of Science:
- Cardiovascular Science
- Biochemistry
- Epidemiology
Background:
- The association between vascular disease and elevated homocysteine levels has been recognized for over 30 years.
- Initial research, including case series, cross-sectional, and case-control studies, consistently indicated a positive relationship between moderate hyperhomocysteinemia and vascular disease risk.
Purpose of the Study:
- To review the limitations and advantages of different study designs in investigating the link between homocysteine and vascular disease.
- To highlight the importance of prospective studies in establishing causality and examining cardiovascular disease manifestations.
Main Methods:
- Review of existing literature, focusing on case series, cross-sectional, case-control, and prospective study designs.
- Analysis of the strengths and weaknesses of each study design in the context of hyperhomocysteinemia and vascular disease research.
Main Results:
- Observational studies consistently suggest a strong positive association between moderate hyperhomocysteinemia and vascular disease.
- Limitations of non-prospective designs include potential confounding by disease or treatment and issues with control group selection.
- Prospective studies offer advantages in minimizing bias and simultaneously studying various cardiovascular disease manifestations.
Conclusions:
- While observational data strongly link elevated homocysteine to vascular disease, prospective studies are essential for confirming causality.
- Understanding the distinct benefits and drawbacks of various research methodologies is critical for advancing knowledge in this field.
Abstract:
The link between vascular disease and elevated homocysteine levels has been recognized for more than 30 years, and an association with moderately elevated levels has been suspected for 20 years. The initial investigations were case series, cross-sectional, and case-control studies. Those studies consistently suggest a strong positive relationship between moderate hyperhomocysteinemia and risk of vascular disease. However, a major limitation of these types of study design is that the possibility of elevated homocysteine levels being influenced by the disease or its treatment cannot be ruled out. In case-control studies there is always concern about the appropriateness of the control group. These issues pose much less of a problem in prospective designs. Prospective studies also offer the opportunity to study various manifestations of cardiovascular disease at the same time. However, prospective studies tend to be more expensive and time-consuming, perhaps explaining the smaller number of prospective studies and why the first was not published until 1992. The distinct limitations and advantages of prospective studies are also reviewed.